These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12047498)

  • 81. Clinical experience with anticonvulsant medication in pediatric epilepsy and comorbid bipolar spectrum disorder.
    Salpekar JA; Conry JA; Doss W; Cushner-Weinstein S; Pearl PL; Weinstein SL; Gaillard WD
    Epilepsy Behav; 2006 Sep; 9(2):327-34. PubMed ID: 16861047
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Efficacy and safety of oxcarbazepine in bipolar disorder.
    Mazza M; Bria P; Mazza S
    Can J Psychiatry; 2007 Apr; 52(4):272; author reply 272-3. PubMed ID: 17500309
    [No Abstract]   [Full Text] [Related]  

  • 83. Oxcarbazepine: an update of its efficacy in the management of epilepsy.
    Wellington K; Goa KL
    CNS Drugs; 2001; 15(2):137-63. PubMed ID: 11460891
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Medications for aggressiveness in prison: focus on oxcarbazepine.
    Mattes JA
    J Am Acad Psychiatry Law; 2012; 40(2):234-8. PubMed ID: 22635296
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The Bipolar Comprehensive Outcomes Study (BCOS): baseline findings of an Australian cohort study.
    Kulkarni J; Berk M; Fitzgerald PB; de Castella AR; Montgomery W; Kelin K; Brnabic A; Granger RE; Dodd S
    J Affect Disord; 2008 Apr; 107(1-3):135-44. PubMed ID: 17889373
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder.
    Davids E; Kis B; Specka M; Gastpar M
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1033-8. PubMed ID: 16698160
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy.
    Grosskopf J; Mazzola J; Wan Y; Hopwood M
    Acta Neurol Scand; 2006 Sep; 114(3):177-80. PubMed ID: 16911345
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Treatment of bipolar disorder in older adults.
    Sajatovic M
    Int J Geriatr Psychiatry; 2002 Sep; 17(9):865-73. PubMed ID: 12221662
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Adjunctive aripiprazole in bipolar I depression.
    Sokolski KN
    Ann Pharmacother; 2007 Jan; 41(1):35-40. PubMed ID: 17190849
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report.
    Emrich HM; Altmann H; Dose M; von Zerssen D
    Pharmacol Biochem Behav; 1983 Aug; 19(2):369-72. PubMed ID: 6415677
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Observational study to evaluate the clinical benefit of lamotrigine add-on therapy in bipolar patients in a naturalistic treatment setting.
    Woo YS; Bahk WM; Pae CU; Jeong JH; Koo BH; Jon DI; Lee JG; Kim MD
    Asia Pac Psychiatry; 2014 Sep; 6(3):334-41. PubMed ID: 24038834
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials.
    Beydoun A
    Pharmacotherapy; 2000 Aug; 20(8 Pt 2):152S-158S. PubMed ID: 10937814
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Concurrent use of efavirenz and oxcarbazepine may not affect efavirenz plasma concentrations.
    Goicoechea M; Best B; Capparelli E; Haubrich R;
    Clin Infect Dis; 2006 Jul; 43(1):116-7. PubMed ID: 16758435
    [No Abstract]   [Full Text] [Related]  

  • 95. A history of substance abuse complicates remission from acute mania in bipolar disorder.
    Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
    J Clin Psychiatry; 1999 Nov; 60(11):733-40. PubMed ID: 10584760
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Oct; 28(10):1211-4. PubMed ID: 18823216
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Mood-stabilizing drugs in depression.
    Shelton RC
    J Clin Psychiatry; 1999; 60 Suppl 5():37-40; discussion 41-2. PubMed ID: 10192406
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome.
    Barrons R; Roberts N
    J Clin Pharm Ther; 2010 Apr; 35(2):153-67. PubMed ID: 20456734
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Brief report: retrospective case series of oxcarbazepine for irritability/agitation symptoms in autism spectrum disorder.
    Douglas JF; Sanders KB; Benneyworth MH; Smith JL; Dejean VM; McGrew SG; Veenstra-Vanderweele J
    J Autism Dev Disord; 2013 May; 43(5):1243-7. PubMed ID: 22976374
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Acute oxcarbazepine overdose in an autistic boy.
    Pedrini M; Noguera A; Vinent J; Torra M; Jiménez R
    Br J Clin Pharmacol; 2009 May; 67(5):579-81. PubMed ID: 19552755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.